Related Experiment Video
Updated: Jun 4, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
[What is the prognosis of chronic immune thrombocytopenia?]
M L Calleja Gero1, J Sevilla, L Madero
1Servicio de Pediatría, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Insights
Most children with chronic immune thrombocytopenia (ITP) achieve remission without treatment. Splenectomy offers good results, but spontaneous recovery is common, suggesting delayed intervention for chronic ITP.
Area of Science:
- Pediatric Hematology
- Immunology
- Clinical Medicine
Context:
- Investigated pediatric chronic immune thrombocytopenia (ITP) cases at Hospital Infantil Universitario Niño Jesús (HIUNJ) from 2003-2008.
- Retrospective analysis of 42 children diagnosed with chronic ITP from a cohort of 288 patients with purpura and other hemorrhagic illnesses.
Purpose:
- To analyze the characteristics of children with chronic ITP.
- To evaluate the prognostic significance of clinical variables (age, gender, initial platelet count, treatment) on ITP outcomes.
Summary:
- Nearly 60% of children with chronic ITP achieved remission without specific treatment, with 23.8% achieving remission post-splenectomy.
- Spontaneous remission occurred in approximately 20% of patients within 6-12 months; clinical variables did not predict disease outcome.
- The term 'chronic ITP' should be reserved for cases lasting over one year due to the high rate of spontaneous remission.
Impact:
- Findings suggest delaying splenectomy in pediatric chronic ITP due to high spontaneous recovery rates and generally benign outcomes.
- Highlights the importance of reconsidering the definition of chronic ITP based on remission timelines.
- Provides insights into the natural history and management strategies for childhood chronic immune thrombocytopenia.
Objectives:
To analyse the characteristics of children with chronic ITP (chronic immune thrombocytopenia) in the Hospital Infantil Universitario Niño Jesús (HIUNJ) between 2003 and 2008. To also evaluate whether clinical variables as age, gender, initial platelet count, and treatment have any prognostic significance on the outcome of ITP.
Patients And Methods:
Data were retrospectively collected from 288 patients diagnosed with "Purpura and other haemorrhagic illnesses". Forty-two out of these 288 satisfied the criteria for "chronic ITP".
Results:
Ten patients out of 42 (23.8%) achieved remission with splenectomy, and 25 (almost 60%) achieved it without splenectomy (14 were complete remissions and 11 were partial remissions). Eight patients (almost 20% of patients with chronic ITP) had spontaneous remissions between 6 and 12 months from initial diagnosis. None of the clinical variables analysed were related to the outcome of the disease and the prognosis of the disease.
Conclusions:
Almost 60% of children with chronic ITP achieve remission without treatment regardless of age, gender, initial treatment or platelet count. Splenectomy is one of the treatments with best results; however the high spontaneous recovery rate in children with cITP, the low percentage of bleeding, and the generally benign outcome should encourage delaying this as long as possible. As it is possible to have a remission between 6 and 12 months from the initial diagnosis, the term "chronic" should be reserved for patients with ITP lasting more than 1 year.
Related Concept Videos
Chronic Inflammation: Introduction
Acute Kidney Injury III: Clinical Manifestations
Regulation of Hematopoietic Stem Cells
Venous Thrombosis III: Interprofessional Care
